<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35061232</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>25</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1439-0973</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Infection</Title><ISOAbbreviation>Infection</ISOAbbreviation></Journal><ArticleTitle>One-year evolution of DLCO changes and respiratory symptoms in patients with post COVID-19 respiratory syndrome.</ArticleTitle><Pagination><StartPage>513</StartPage><EndPage>517</EndPage><MedlinePgn>513-517</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s15010-022-01755-5</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">During a follow-up program of patients admitted for COVID-19 at our non-ICU Unit, we found that 37% of them had decreased diffusing lung capacity for carbon monoxide (DLCO) 3-6&#xa0;months after discharge. This prospective observational study aimed to evaluate the evolution of changes in DLCO and respiratory symptoms at the 1-year follow-up visit.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Seventeen (mean age 71&#xa0;years; 8 males) of 19 eligible patients (DLCO&#x2009;&lt;&#x2009;80% of predicted at the 3-6&#xa0;months follow-up visit) completed the 1-year follow-up visit. One patient refused to participate and 1 patient had died 3&#xa0;months earlier from myocardial infarction. The visit included a self-reported structured questionnaire, physical exam, blood tests, ECG, and spirometry with DLCO.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Mean DLCO was significantly improved at the 1-year visit (from 64% of predicted at 3-6&#xa0;months to 74% of predicted at 1&#xa0;year; P&#x2009;=&#x2009;0.003). A clinically significant increase in DLCO (10% or greater) was observed in 11 patients (65%) with complete normalization (&gt;&#x2009;80% of predicted) in 6 (35%); in the other 6 (35%) it remained unchanged. The prevalence of exertional dyspnea (65-35%, P&#x2009;=&#x2009;0.17), cough (24-18%, P&#x2009;=&#x2009;1), and fatigue (76-35%, P&#x2009;=&#x2009;0.04) decreased at the 1-year visit.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">These results suggest that DLCO and respiratory symptoms tend to normalize or improve 1&#xa0;year after hospitalization for COVID-19 in most patients. However, there is also a non-negligible number of patients (about one-third) in whom respiratory changes persist and will need prolonged follow-up.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fortini</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0156-3142</Identifier><AffiliationInfo><Affiliation>Internal Medicine, San Giovanni di Dio Hospital, Via di Torregalli 3, 50143, Florence, Italy. xfortini@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosso</LastName><ForeName>Aurelio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Internal Medicine, San Giovanni di Dio Hospital, Via di Torregalli 3, 50143, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cecchini</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Pneumology, San Giovanni di Dio Hospital, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torrigiani</LastName><ForeName>Arianna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Internal Medicine, San Giovanni di Dio Hospital, Via di Torregalli 3, 50143, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lo Forte</LastName><ForeName>Aldo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Internal Medicine, San Giovanni di Dio Hospital, Via di Torregalli 3, 50143, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carrai</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Internal Medicine, San Giovanni di Dio Hospital, Via di Torregalli 3, 50143, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alessi</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Internal Medicine, San Giovanni di Dio Hospital, Via di Torregalli 3, 50143, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fabbrizzi</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Internal Medicine, San Giovanni di Dio Hospital, Via di Torregalli 3, 50143, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lovicu</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Internal Medicine, San Giovanni di Dio Hospital, Via di Torregalli 3, 50143, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sbaragli</LastName><ForeName>Serena</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Internal Medicine, San Giovanni di Dio Hospital, Via di Torregalli 3, 50143, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faraone</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Internal Medicine, San Giovanni di Dio Hospital, Via di Torregalli 3, 50143, Florence, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Infection</MedlineTA><NlmUniqueID>0365307</NlmUniqueID><ISSNLinking>0300-8126</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010351" MajorTopicYN="N">Patient Discharge</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013147" MajorTopicYN="N">Spirometry</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DLCO</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Post-acute sequelae of SARS-CoV-2 infection</Keyword><Keyword MajorTopicYN="N">Respiratory symptoms</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>21</Day><Hour>12</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35061232</ArticleId><ArticleId IdType="pmc">PMC8777423</ArticleId><ArticleId IdType="doi">10.1007/s15010-022-01755-5</ArticleId><ArticleId IdType="pii">10.1007/s15010-022-01755-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortini A, Torrigiani A, Sbaragli S, et al. COVID-19: persistence of symptoms and lung alterations after 3&#x2013;6 months from hospital discharge. Infection. 2021;49:1007&#x2013;1015. doi: 10.1007/s15010-021-01638-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01638-1</ArticleId><ArticleId IdType="pmc">PMC8179958</ArticleId><ArticleId IdType="pubmed">34091869</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang DH, Roy DJ, Gu BJ, Hassett LC, McCoy RG. Postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection: a state-of-the-art review. JACC Basic Transl Sci. 2021;6:796&#x2013;811. doi: 10.1016/j.jacbts.2021.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacbts.2021.07.002</ArticleId><ArticleId IdType="pmc">PMC8442719</ArticleId><ArticleId IdType="pubmed">34541421</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948&#x2013;968. doi: 10.1183/09031936.05.00035205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.05.00035205</ArticleId><ArticleId IdType="pubmed">16264058</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruet M. Fatigue in chronic respiratory diseases: theoretical framework and implications for real-life performance and rehabilitation. Front Physiol. 2018;9:1285. doi: 10.3389/fphys.2018.01285.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.01285</ArticleId><ArticleId IdType="pmc">PMC6156387</ArticleId><ArticleId IdType="pubmed">30283347</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Liu X, Zhou Y, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med. 2021;9:747&#x2013;754. doi: 10.1016/S2213-2600(21)00174-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00174-0</ArticleId><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398:747&#x2013;758. doi: 10.1016/S0140-6736(21)01755-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker C, Beck K, Zumbrunn S, et al. Long COVID 1 year after hospitalisation for COVID-19: a prospective bicentric cohort study. Swiss Med Wkly. 2021;151:w30091. doi: 10.4414/smw.2021.w30091.</Citation><ArticleIdList><ArticleId IdType="doi">10.4414/smw.2021.w30091</ArticleId><ArticleId IdType="pubmed">34694106</ArticleId></ArticleIdList></Reference><Reference><Citation>Vianello A, Guarnieri G, Braccioni F, et al. The pathogenesis, epidemiology and biomarkers of susceptibility of pulmonary fibrosis in COVID-19 survivors. Clin Chem Lab Med. 2021 doi: 10.1515/cclm-2021-1021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2021-1021</ArticleId><ArticleId IdType="pubmed">34783228</ArticleId></ArticleIdList></Reference><Reference><Citation>Spagnolo P, Balestro E, Aliberti S, et al. Pulmonary fibrosis secondary to COVID-19: a call to arms? Lancet Respir Med. 2020;8:750&#x2013;752. doi: 10.1016/S2213-2600(20)30222-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30222-8</ArticleId><ArticleId IdType="pmc">PMC7228737</ArticleId><ArticleId IdType="pubmed">32422177</ArticleId></ArticleIdList></Reference><Reference><Citation>Boehm A, Luger AK, Schmitz K, et al. A spark of hope: histopathological and functional recovery after critical COVID-19. Infection. 2021 doi: 10.1007/s15010-021-01678-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01678-7</ArticleId><ArticleId IdType="pmc">PMC8386898</ArticleId><ArticleId IdType="pubmed">34435313</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P, Li J, Liu H, et al. Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study. Bone Res. 2020;8:8. doi: 10.1038/s41413-020-0084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41413-020-0084-5</ArticleId><ArticleId IdType="pmc">PMC7018717</ArticleId><ArticleId IdType="pubmed">32128276</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>